Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Pediatr Infect Dis J ; 31(8): e117-25, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22581223

ABSTRACT

BACKGROUND: Treatment of HIV-1 infected Ugandan children with antiretroviral therapy (ART) is increasing, but few prospective long-term studies evaluating the treatment process have been reported. In this study, we sought to determine prospectively how consistent monitoring of HIV-1 RNA levels affects the ART treatment process. METHODS: One hundred eight children initiating ART were enrolled into this study. These children had comprehensive laboratory monitoring, including HIV-1 RNA level determination and genotype analysis (where appropriate), CD4% plus absolute counts and safety laboratory measurements performed before starting therapy and at regular intervals after receiving ART. Kaplan-Meier statistics were used to examine predictors of survival and virologic failure. Viral genotype analysis was performed on samples obtained from children having virologic failure to determine the emergence of mutations. RESULTS: Clinically, there was no difference in the 3-year survival between our cohort receiving consistent laboratory monitoring and a matched historical clinic cohort not routinely receiving laboratory monitoring. However, 34% of children receiving ART demonstrated virologic failure. Eleven of these children received second-line ART, and all responded with an undetectable HIV-1 RNA level and an increase in CD4 count. Children remaining on a failing antiretroviral regimen accumulated resistance mutations. CONCLUSIONS: Our prospective long-term findings support the general use of monitoring HIV-1 RNA levels for the management of children on ART and the adoption of a clearer definition for virologic failure and better guidelines for managing children with unsuppressed HIV-1 RNA levels.


Subject(s)
Anti-Retroviral Agents/therapeutic use , HIV Infections/drug therapy , Adolescent , Anti-Retroviral Agents/adverse effects , CD4 Lymphocyte Count , Child , Child, Preschool , Drug Resistance, Viral , Female , HIV Infections/blood , HIV Infections/virology , HIV-1/genetics , HIV-1/isolation & purification , Humans , Infant , Kaplan-Meier Estimate , Male , Mutation , Prospective Studies , RNA, Viral/blood , Treatment Outcome , Uganda , Viral Load
2.
Invest Ophthalmol Vis Sci ; 49(9): 3992-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18487372

ABSTRACT

PURPOSE: Previous studies demonstrated that mast cell-derived TNFalpha stimulation is critical to the upregulation of intercellular adhesion molecule (ICAM)-1 on human conjunctival epithelial cells (HCECs), which is an important feature of ocular allergic inflammation. Shedding of TNFR1 by TNFalpha-converting enzyme (TACE) is a primary mechanism for the regulation of TNFalpha-mediated events. This process has not been examined in HCECs. In this study, the authors examined the regulation of TNFR1 expression and shedding by TACE on primary HCECs and the IOBA-NHC conjunctival epithelial cell line. METHODS: Primary human conjunctival mast cells and epithelial cells were obtained from cadaveric conjunctival tissue. HCECs were incubated with and without activators (IgE-activated mast cell supernates, phorbol myristate acetate [PMA; to activate TACE], TNFalpha, and IFNgamma [to upregulate TNFR1]) for 24 hours. Pretreatment with the TACE inhibitor TAPI-2 was used to inhibit shedding of TNFR1. Supernates collected from the incubations were analyzed with ELISA for soluble TNFR1 (sTNFR1). With the use of flow cytometry, cells were harvested from these experiments for analysis of TNFR1 and ICAM-1 receptor expression. RESULTS: IgE-activated conjunctival mast cell supernates upregulated the expression of TNFR1. TAPI-2 inhibited the PMA-induced release of sTNFR1 receptor and enhanced the surface expression of TNFR1 in HCECs in a dose-dependent manner. Upregulation of TNFR1 expression by priming with TAPI-2 and IFNgamma resulted in enhanced ICAM-1 expression in response to TNFalpha stimulation (significant change in the slope of the dose-response curve). CONCLUSIONS: These results demonstrate that TACE promotes TNFR1 shedding in HCECs and that TNFR1 expression may be a more significant target than TNFalpha for intervention in ocular inflammation.


Subject(s)
Conjunctiva/cytology , Conjunctiva/physiology , Epithelial Cells/cytology , Epithelial Cells/physiology , Mast Cells/cytology , Receptors, Tumor Necrosis Factor, Type I/physiology , Tumor Necrosis Factor-alpha/physiology , ADAM Proteins/metabolism , ADAM17 Protein , Cell Culture Techniques , Culture Media , Humans , Hydroxamic Acids/pharmacology , Receptors, Tumor Necrosis Factor, Type I/antagonists & inhibitors , Receptors, Tumor Necrosis Factor, Type I/metabolism , Tetradecanoylphorbol Acetate/pharmacology
3.
Bioinformatics ; 24(6): 855-60, 2008 Mar 15.
Article in English | MEDLINE | ID: mdl-18187444

ABSTRACT

MOTIVATION: We present a spatial-temporal (ST) human immunodeficiency virus (HIV) simulation model to investigate the spatial distribution of viral load and T-cells during HIV progression. The proposed model uses the Finite Element (FE) method to divide a considered infected region into interconnected subregions each containing viral population and T-cells. HIV T-cells and viral load are traced and counted within and between subregions to estimate their effect upon neighboring regions. The objective is to estimate overall ST changes of HIV progression and to study the ST therapeutic effect upon HIV dynamics in spatial and temporal domains. We introduce sub-regional (spatial) parameters of T-cells and viral load production and elimination to estimate the spatial propagation and interaction of HIV dynamics under the influence of a 3TC D4T Reverse Transcriptase Inhibitors (RTI) drug regimen. RESULTS: In terms of percentage change standard deviation, we show that the average rate per 10 weeks (throughout a 10-year clinical trial) of the ST CD4+ change is 5.35% 1.3 different than that of the CD4+ rate of change in laboratory datasets, and the average rate of change of the ST CD8+ is 4.98% 1.93 different than that of the CD8+ rate of change. The half-life of the ST CD4+ count is 1.68% 3.381 different than the actual half-life of the CD4+ count obtained from laboratory datasets. The distribution of the viral load and T-cells in a considered region tends to cluster during the HIV progression once a threshold of 86-89% viral accumulation is reached. AVAILABILITY: Executable code and data libraries are available by contacting the corresponding author. IMPLEMENTATION: C++ and Java have been used to simulate the suggested model. A Pentium III or higher platform is recommended.


Subject(s)
HIV Infections/immunology , HIV Infections/virology , HIV/immunology , Models, Immunological , T-Lymphocytes/immunology , T-Lymphocytes/virology , Viral Load/methods , Anti-HIV Agents/administration & dosage , Computer Simulation , Disease Progression , HIV/drug effects , HIV Infections/drug therapy , Humans , Reverse Transcriptase Inhibitors/administration & dosage , T-Lymphocytes/drug effects
4.
Invest Ophthalmol Vis Sci ; 47(8): 3423-9, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16877412

ABSTRACT

PURPOSE: The mechanism by which eosinophils adhere to the ocular surface during allergic inflammation is unknown. This study examined whether the incubation of human conjunctival epithelial cells (HCEs) with tears from allergic subjects promotes eosinophil adhesion, and it examined the effect of treatment with olopatadine on this process. METHODS: Allergic subjects (n = 6) and nonallergic subjects (n = 4) were treated in season for 1 week with olopatadine in one eye while the other eye remained untreated. Tears were collected from both eyes with the use of a microcapillary tube. HCEs were acquired by enzymatic digestion of cadaveric conjunctival tissues. Confluent cultures of HCEs were treated with diluted tears for 24 hours before incubation with peripheral blood eosinophils (purified with negative magnetic bead selection). Eosinophil adhesion was measured with an eosinophil peroxidase assay. RESULTS: Incubation of HCEs with tears from allergic subjects significantly upregulated eosinophil adhesion compared with eosinophil adhesion to untreated HCEs or with HCEs treated with nonallergic tears and untreated HCEs (P < 0.05). Eosinophil adhesion to HCEs treated with tears from olopatadine-treated allergic subjects was inhibited (P < 0.01) compared with tear-stimulated adhesion observed from untreated eyes. Percentage of inhibition was 43.3% +/- 13.9% (mean +/- SD). Blocking antibodies demonstrated that eosinophil adhesion to HCEs in vitro involved beta2 integrins on eosinophils but not intercellular adhesion molecule-1 on human HCEs. CONCLUSIONS: Tears collected from allergic subjects contain bioactivity capable of upregulating eosinophil adhesion to HCEs in vitro. Inhibition of this process by treatment of subjects with olopatadine suggests that some of the cellular targets of this drug may play a role in promoting eosinophil adhesion.


Subject(s)
Anti-Allergic Agents/therapeutic use , Conjunctiva/cytology , Conjunctivitis, Allergic/immunology , Dibenzoxepins/therapeutic use , Eosinophils/metabolism , Epithelial Cells/metabolism , Tears/physiology , Adult , Antibodies, Blocking , CD18 Antigens/metabolism , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cell Separation , Cells, Cultured , Conjunctivitis, Allergic/drug therapy , Female , Humans , Intercellular Adhesion Molecule-1/metabolism , Male , Middle Aged , Models, Biological , Olopatadine Hydrochloride , Skin Tests , Up-Regulation
5.
Toxicology ; 222(1-2): 25-36, 2006 May 01.
Article in English | MEDLINE | ID: mdl-16473451

ABSTRACT

Sulfamethoxazole (SMX) is an effective drug for the management of opportunistic infections, but its use is limited by hypersensitivity reactions, particularly in HIV-infected patients. The oxidative metabolite SMX-nitroso (SMX-NO), is thought to be a proximate mediator of SMX hypersensitivity, and can be reduced in vitro by ascorbate or glutathione. Leukocytes from patients with SMX hypersensitivity show enhanced cytotoxicity from SMX metabolites in vitro; this finding has been attributed to a possible "detoxification defect" in some individuals. The purpose of this study was to determine whether variability in endogenous ascorbate or glutathione could be associated with individual differences in SMX-NO cytotoxicity. Thirty HIV-positive patients and 23 healthy control subjects were studied. Both antioxidants were significantly correlated with the reduction of SMX-NO to its hydroxylamine, SMX-HA, by mononuclear leukocytes, and both were linearly depleted during reduction. Controlled ascorbate supplementation in three healthy subjects increased leukocyte ascorbate with no change in glutathione, and significantly enhanced SMX-NO reduction. Ascorbate supplementation also decreased SMX-NO cytotoxicity compared to pre-supplementation values. Rapid reduction of SMX-NO to SMX-HA was associated with enhanced direct cytotoxicity from SMX-NO. When forward oxidation of SMX-HA back to SMX-NO was driven by the superoxide dismutase mimetic, Tempol, SMX-NO cytotoxicity was increased, without enhancement of adduct formation. This suggests that SMX-NO cytotoxicity may be mediated, at least in part, by redox cycling between SMX-HA and SMX-NO. Overall, these data indicate that endogenous ascorbate and glutathione are important for the intracellular reduction of SMX-NO, a proposed mediator of SMX hypersensitivity, and that redox cycling of SMX-HA to SMX-NO may contribute to the cytotoxicity of these metabolites in vitro.


Subject(s)
Ascorbic Acid/metabolism , Glutathione/metabolism , HIV Infections/metabolism , Leukocytes, Mononuclear/metabolism , Sulfamethoxazole/analogs & derivatives , Adult , Aged , Antioxidants/pharmacology , Ascorbic Acid/administration & dosage , Ascorbic Acid/analysis , Cell Separation , Cyclic N-Oxides/pharmacology , Drug Hypersensitivity/etiology , Female , Glutathione/analysis , HIV Infections/blood , Humans , Leukocytes, Mononuclear/drug effects , Male , Middle Aged , Oxidation-Reduction , Spin Labels , Sulfamethoxazole/analysis , Sulfamethoxazole/chemistry , Sulfamethoxazole/metabolism , Sulfamethoxazole/toxicity
6.
Ann Allergy Asthma Immunol ; 94(4): 486-97, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15875531

ABSTRACT

BACKGROUND: Staphylococcus aureus colonization is common in atopic keratoconjunctivitis, potentially activating epithelial cells via toll-like receptor 2 (TLR-2) and the receptor for platelet-activating factor (PAFR). OBJECTIVES: To examine human conjunctival epithelial cells for the expression of TLR-2 in vitro and in vivo and to evaluate the role of TLR-2 in S aureus-mediated activation of these cells. METHODS: Conjunctival epithelial cells isolated from cadaveric tissues were stimulated with interferon gamma (IFN-gamma) or a commercial S aureus cell wall extract (Staphylococcus aureus-CWE) (with or without anti-TLR-2 blocking antibody or PAFR antagonist) and were analyzed for tumor necrosis factor alpha (TNF-alpha) and interleukin 8 (IL-8) release; surface expression of TLR-2, intercellular adhesion molecule-1, HLA, and CD14; and TLR-2 messenger RNA expression. Ocular surface cells collected via impression cytology were examined for TLR-2 expression via flow cytometry. RESULTS: Expression of TLR-2 was up-regulated on conjunctival epithelial cells by IFN-gamma and Staphylococcus aureus-CWE. Expression of TLR-2 messenger RNA was increased by IFN-gamma. Staphylococcus aureus-CWE up-regulated intercellular adhesion molecule 1, HLA, and CD14 expression and increased TNF-alpha and IL-8 release in a dose-dependent manner. Anti-TLR-2 significantly inhibited TNF-alpha release, whereas PAFR antagonist significantly inhibited IL-8 release. Toll-like receptor 2 was expressed on conjunctival epithelial cells from 4 of 5 patients with atopic keratoconjunctivitis, 3 of 5 with seasonal allergies, and 0 of 3 without allergies. CONCLUSIONS: Conjunctival epithelial cells express TLR-2 and may play an active role in the chronic ocular inflammatory response to S aureus through pathways that involve TLR-2 and PAFR.


Subject(s)
Conjunctiva/immunology , Conjunctivitis/microbiology , Membrane Glycoproteins/immunology , Receptors, Cell Surface/immunology , Staphylococcal Infections/immunology , Staphylococcus aureus/immunology , Adolescent , Adult , Blotting, Northern , Conjunctiva/microbiology , Conjunctivitis/immunology , Epithelial Cells/immunology , Epithelial Cells/microbiology , Female , HLA-DR Antigens/immunology , Humans , Intercellular Adhesion Molecule-1/immunology , Interferon-gamma/immunology , Interleukin-8/immunology , Lipopolysaccharide Receptors/immunology , Male , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/genetics , Middle Aged , RNA, Messenger/chemistry , RNA, Messenger/genetics , Receptors, Cell Surface/biosynthesis , Receptors, Cell Surface/genetics , Staphylococcal Infections/microbiology , Toll-Like Receptor 2 , Toll-Like Receptors , Tumor Necrosis Factor-alpha/immunology
7.
J Acquir Immune Defic Syndr ; 36(5): 1041-50, 2004 Aug 15.
Article in English | MEDLINE | ID: mdl-15247557

ABSTRACT

OBJECTIVE: The objective of these studies was to determine the role of ascorbate deficiency in HIV infection in the defective detoxification of sulfamethoxazole-nitroso, the metabolite thought to mediate sulfonamide hypersensitivity reactions. METHODS: Fifty-one HIV-infected patients and 26 healthy volunteers were evaluated. Vitamin supplementation histories were obtained, and blood samples were collected for determination of plasma ascorbate, dehydroascorbate, and cysteine concentrations, erythrocyte glutathione concentrations, and plasma reduction of sulfamethoxazole-nitroso in vitro. RESULTS: Plasma ascorbate concentrations were significantly lower in HIV-positive patients not taking vitamin supplements (29.5 +/- 22.3 microM) than in healthy subjects (54.8 +/- 22.3 microM; P = 0.0005) and patients taking 500-1000 mg of ascorbate daily (82.5 +/- 26.3 microM; P < 0.0001). Plasma ascorbate deficiency was strongly correlated with impaired reduction of sulfamethoxazole-nitroso to its hydroxylamine (r = 0.60, P < 0.0001), and during in vitro reduction, the loss of plasma ascorbate was strongly associated with the amount of nitroso reduced (r = 0.70, P < 0.0001). Ascorbate added ex vivo normalized this reduction pathway. Erythrocyte glutathione concentrations were significantly lower in HIV-positive patients (0.98+/-0.32 mM) than in healthy subjects (1.45+/-0.49 mM; P = 0.001), but this finding was unrelated to ascorbate supplementation. There was trend toward lower plasma cysteine concentrations in patients (8.4+/-3.9 microM) than in controls (10.3+/-4.3 microM), but this trend was similarly unrelated to ascorbate supplementation. Dehydroascorbate concentrations were not significantly higher in HIV-positive patients (7.4+/-10.5%) than in healthy controls (4.0+/-6.2%), even in the subset of patients taking ascorbate (8.4+/-9.4%). CONCLUSIONS: Ascorbate deficiency is common in HIV-positive patients and is associated with impaired detoxification of sulfamethoxazole-nitroso, the suspected proximate toxin in sulfonamide hypersensitivity. Patients taking daily ascorbate supplements (500-1000 mg) achieved high plasma ascorbate concentrations and did not show this detoxification defect. Ascorbate deficiency (or supplementation) was not associated with changes in glutathione or cysteine concentrations. These data suggest that ascorbate deficiency, independent of thiol status, may be an important determinant of impaired drug detoxification in HIV infection.


Subject(s)
Ascorbic Acid Deficiency/complications , Ascorbic Acid Deficiency/metabolism , HIV Infections/complications , HIV Infections/metabolism , Sulfamethoxazole/analogs & derivatives , Adult , Anti-Infective Agents/metabolism , Ascorbic Acid/blood , CD4-CD8 Ratio , Case-Control Studies , Cysteine/blood , Dehydroascorbic Acid/blood , Female , Glutathione/blood , HIV Infections/immunology , Humans , In Vitro Techniques , Male , Middle Aged , Oxidation-Reduction , Sulfamethoxazole/metabolism
8.
Ann Allergy Asthma Immunol ; 92(1): 65-72, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14756467

ABSTRACT

BACKGROUND: Allergen-mediated mast cell activation is a key feature of ocular allergic diseases. Evidence of eosinophil-derived mediators in tears and conjunctival biopsy specimens has been associated with chronic ocular allergic inflammation. OBJECTIVE: To examine the role of conjunctival mast cell mediators in eosinophil adhesion to conjunctival epithelial cells and eosinophil degranulation. METHODS: Conjunctival cells were obtained by enzymatic digestion of cadaveric conjunctival tissues. Eosinophils were obtained from peripheral blood samples using negative magnetic bead selection. The effect of IgE-activated mast cell supernates on eosinophil degranulation and adherence to epithelial cells was compared with supernates obtained from mast cells pretreated with a degranulation inhibitor (olopatadine). Eosinophil adhesion was measured by eosinophil peroxidase assay, and eosinophil degranulation was measured by eosinophil-derived neurotoxin radioimmunoassay. RESULTS: IgE-activated conjunctival mast cell supernates stimulated adhesion of eosinophils to epithelial cells (20.4% +/- 6.3% vs 3.1% +/- 1.0%; P = .048). Degranulation was not required for this process (no effect of olopatadine). IgE-activated mast cell supernates stimulated eosinophil-derived neurotoxin release (108.89 +/- 8.27 ng/10(6) cells vs 79.45 +/- 5.21 ng/10(6) cells for controls, P = .02), which was significantly inhibited by pretreatment of mast cells with a degranulation inhibitor (79.22 +/- 4.33 ng/10(6) cells vs 61.09 +/- 5.39 ng/10(6) cells for olopatadine pretreated and untreated, respectively, P = .02). CONCLUSIONS: Mediators released from conjunctival mast cells promote eosinophil adhesion to conjunctival epithelial cells and eosinophil degranulation. Degranulation inhibition studies suggest that different mast cell mediators are involved in regulation of these events.


Subject(s)
Cell Degranulation , Conjunctiva/cytology , Eosinophils/physiology , Epithelial Cells/physiology , Mast Cells/immunology , Adolescent , Adult , Asthma/immunology , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cell Degranulation/drug effects , Cell Degranulation/physiology , Dibenzoxepins/pharmacology , Female , Humans , Immunoglobulin E/immunology , Male , Middle Aged , Olopatadine Hydrochloride , Rhinitis, Allergic, Perennial/immunology
9.
Invest Ophthalmol Vis Sci ; 44(5): 2010-5, 2003 May.
Article in English | MEDLINE | ID: mdl-12714637

ABSTRACT

PURPOSE: To gain better understanding of conjunctival epithelial cell responses to proinflammatory cytokines, the individual and combined effects of TNFalpha, IL-1beta, and IFNgamma on chemokine release (IL-8, regulated on activation normal T-cell expressed and secreted [RANTES]) and surface receptor expression (intercellular adhesion molecule [ICAM]-1, and HLA-DR, -DP, and -DQ) were examined. METHODS: Conjunctival epithelial cells were isolated from cadaveric conjunctival tissues and cultured in 24-well plates until almost confluent. Recombinant cytokines (0.005-50 ng/mL) were added, alone or in various combinations, 24 hours before harvesting of supernates for ELISAs and cells for flow cytometry. RESULTS: TNFalpha, IL-1beta, and IFNgamma had distinctive individual and combined effects on the parameters tested. Although TNFalpha and IL-1beta had similar and synergistic effects on increasing expression of ICAM-1, IL-1beta was a more potent upregulator of the release of IL-8 than was TNFalpha. Upregulation of IL-8 was additive when IL-1beta was combined with TNFalpha. Neither TNFalpha nor IL-1beta increased expression of HLA. In contrast, IFNgamma was a potent upregulator of both surface receptors (ICAM-1 and HLA) but IFNgamma alone had no effect on mediator release (IL-8 and RANTES). Release of RANTES required two cytokine signals, with IFNgamma and TNFalpha being the most potent combination. CONCLUSIONS: Knowledge of the differential and combined effects of proinflammatory cytokines on conjunctival epithelial cells allows better understanding of ocular inflammation.


Subject(s)
Chemokines/metabolism , Conjunctiva/drug effects , Histocompatibility Antigens Class II/metabolism , Intercellular Adhesion Molecule-1/metabolism , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Cell Separation , Cells, Cultured , Chemokine CCL5/metabolism , Conjunctiva/cytology , Conjunctiva/metabolism , Drug Combinations , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/drug effects , Flow Cytometry , Humans , Interleukin-8/metabolism , Up-Regulation
10.
Curr Allergy Asthma Rep ; 2(4): 332-9, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12044270

ABSTRACT

Allergic eye disease is associated with IgE-mediated conjunctival inflammation leading to signs of immediate hypersensitivity, including redness, itching, and tearing. Pathologic studies using conjunctival mast cells demonstrate that these cells, when sensitized with IgE antibody and exposed to environmental allergens, release mediators involved with allergic inflammation. The type, release kinetics, and concentration of these mediators in the conjunctiva have not been completely characterized. The ability to isolate and purify mast cells and epithelial cells from human conjunctival tissue has permitted the study of mediator release and cell-to-cell signaling in this tissue. Our laboratory has developed in vitro and in vivo models to better understand how inflammatory cells are recruited to and infiltrate conjunctival tissues. These models demonstrate that mast-cell activation may supply sufficient cytokine signaling to initiate and direct the well-orchestrated trafficking of eosinophils to the ocular surface, facilitate their adhesion, and cause release of potent mediators of ocular inflammation.


Subject(s)
Conjunctiva/pathology , Conjunctivitis, Allergic/pathology , Epithelial Cells/pathology , Mast Cells/pathology , Conjunctiva/immunology , Conjunctivitis, Allergic/immunology , Cytokines/immunology , Epithelial Cells/immunology , Humans , Immunoglobulin E/immunology , Intercellular Adhesion Molecule-1/immunology , Mast Cells/immunology , Receptors, IgE/immunology
11.
Postgrad Med ; 94(8): 165-180, 1993 Dec.
Article in English | MEDLINE | ID: mdl-29206547

ABSTRACT

Preview Once considered relatively benign, rheumatoid arthritis is now recognized as a disabling systemic disease that causes substantial morbidity and mortality. Early, aggressive therapy may be critical for altering the course of disease. Drs Vikings-son and Graziano describe the causes and clinical course of rheumatoid arthritis and discuss diagnostic considerations and prognostic indicators that support optimum management.

SELECTION OF CITATIONS
SEARCH DETAIL
...